Academician of Chinese Academy of Sciences: five fields of biomedical industry in China have broad prospects

Kunming, Dec 4, Xinhua (reporter Wu Xiaoyang) Rao Zihe, academician of the Chinese Academy of Sciences and President of Nankai University, said in a speech in Kunming on the 3rd that China's biomedical industry is expected to grow into a pillar industry of 600-800 billion yuan, with the focus on the development of new vaccines and the transformation of biotechnological drugs such as traditional vaccines, antibody drugs and protein drugs Industrialization, research and product development of major disease diagnosis and detection technology, research and application of biotherapy technology such as gene therapy and cell therapy, and regenerative medicine technology According to academician Rao Zihe, China's biomedical industry has broad prospects, but at present, it faces challenges such as weak foundation, less investment, lack of top talents and weak innovation ability The vast majority of biotechnology innovation and patents come from developed countries, for example, 59% of biotechnology patents come from the United States, 19% from Europe, 17% from Japan The key development directions of China's biomedical industry include the following five aspects: First, we will vigorously develop new vaccines and transform traditional vaccines China is the country with the largest amount of vaccine use in the world, and the number of vaccine use reaches up to 100 million per year The popularization and application of vaccines have made great contribution to the improvement of life expectancy in China, but at present, vaccines developed 50 years ago or even earlier are still widely used in China It is an inevitable trend to develop new vaccines and transform traditional vaccines, which will help greatly improve the prevention and control ability of major infectious diseases, and cultivate a vaccine industry of 100-150 billion yuan The second is the industrialization of antibody drugs and protein drugs In view of malignant tumor, cardiovascular and cerebrovascular diseases, neurodegenerative diseases, diabetes, autoimmune diseases and other diseases that seriously harm people's health, biotechnology drugs have become the fastest growing drugs in the world At present, the market scale of biotechnological drugs in China is about 40 billion yuan, and it is expected to cultivate an industry of 300-500 billion yuan in the future Third, research and product development of major disease diagnosis and detection technology The outbreak of SARS, avian influenza, tuberculosis, AIDS and influenza A (H1N1) requires the development of diagnostic technology and related industries In the future, it is expected to cultivate a diagnosis and detection market of about 50 billion yuan Fourth, strengthen gene therapy, cell therapy and other biological treatment technologies At present, six stem cell therapy products in China are undergoing clinical trials at different stages, and the research and development of nucleic acid drugs keep pace with the world By 2015, the global potential market for stem cell medicine will be about US $80 billion, and the market for nucleic acid drugs will reach US $200 billion In the future, China is expected to cultivate a personalized treatment system of RMB 100 billion Fifth, the research and application of regenerative medicine technology There is a huge demand for tissue engineering products in the world It is estimated that the market of tissue engineering products can reach 80 billion US dollars By 2020, 95% of transplanted cells, tissues and organs will be produced by tissue engineering technology There are many organ defects caused by trauma, disease, heredity and aging in China It is expected to cultivate a regeneration treatment and rehabilitation market of 50 billion yuan.